Background: We sought to evaluate and validate the 8th edition of the AJCC classification using a
T-category performed slightly better than AJCC 7th edition with a C-index of 0.609 versus 0.590.
Conclusions: A staging system that perfectly discriminates between stages has not yet been developed, but the AJCC 8th edition was able to better stratify the risk of death of Stage III and T3 patients.
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| INTRODUCTION
Although intrahepatic cholangiocarcinoma (ICC) has historically been considered a relatively uncommon disease, its incidence is increasing worldwide. As a consequence, a growing body of evidence on factors associated with long-term outcomes of ICC patients has emerged. [1] [2] [3] [4] [5] [6] [7] [8] The importance of ICC has been recently recognized by the American Joint Committee on Cancer (AJCC) with the 7th edition of the AJCC Staging Manual incorporating a tumor-node-metastasis (TNM) staging system for ICC distinct from hepatocellular carcinoma (HCC) and extrahepatic bile duct malignancies. 9 In the AJCC 7th edition, T-category was based on three major prognostic factors including tumor number, vascular invasion, and direct extrahepatic extension derived from the work of Nathan et al. 10 N-category was based on the presence or absence of metastasis in one or more regional lymph nodes; specifically, for a left-sided ICC, nodal disease in the common bile duct, hepatic artery, portal vein, and cystic duct nodes, while for a right-sided ICC, the nodal basins of interest were hilar, periduodenal, and peripancreatic. The 7th edition of the AJCC staging system was subsequently validated in several different cohorts. [11] [12] [13] [14] [15] [16] Over time, however, several groups proposed modifications to the staging system. For example, Igami et al advocated for replacing periductal invasion with multiple tumors for T4 disease, as well as categorizing nodal metastasis in the gastrohepatic lymph node basin as distant metastasis. 13 Recently, the 8th edition of the AJCC staging manual was published. 17 In this edition, ICC staging remained independent of the staging systems for HCC and extrahepatic bile duct cholangiocarcinomas, yet mixed hepato-cholangio carcinomas and rare intrahepatic primary neuroendocrine tumors were included in the staging system.
Importantly, the 8th edition of the AJCC staging system introduced several notable changes to the T-category classification schema. In particular, T1 disease has been modified to account for the prognostic impact of tumor size (T1a, solitary tumor ≤5 cm vs. T1b, solitary tumor >5 cm). T2 has been revised to reflect the equivalent prognostic effect of tumor number and vascular invasion (T2, solitary tumor with intrahepatic vascular invasion or multiple tumors, with or without vascular invasion). In addition, T4 disease, which previously was based on tumor growth pattern, has been excluded from the 8th edition.
Given the recent introduction of this new staging system, the objective of the current study was to evaluate and validate the new edition of the AJCC staging system using a large multi-institutional cohort of patients with ICC.
invasion, perforation of the visceral peritoneum, and regional lymph node involvement, as defined by high-resolution cross-sectional imaging, biopsy tissue and surgical pathology. 17 Presence of vascular/perineural/biliary invasion, and direct invasion of contiguous organs were also recorded. Data on tumor stage were collected according to both the 7th and the 8th edition AJCC staging systems. 9 Perioperative complications and mortality were considered within 90 days from the operation. 18 (Table 2 and Fig. 1b) .
| Statistical analysis
When patients were categorized using the AJCC 7th edition T-category system, T2a, T2b, and T4 patients had a higher HR of death compared with T1 (AJCC 7th ed., T2a vs. T1, HR 1.43 95% CI, Table S2 ).
| DISCUSSION
Staging of ICC has historically mirrored the staging system for HCC and extrahepatic cholangiocarcinoma, largely due to the fact that ICC is a relatively uncommon disease. However, over the last decade there has been an increased recognition of ICC as a distinct clinical entity. Following the introduction of the first unique staging system for ICC in the 7th edition AJCC staging manual, the staging of ICC has continued to evolve. [11] [12] [13] [14] [15] [16] Several staging systems have been proposed; for example, in addition to the AJCC staging system in Western Countries, the Liver Cancer Study Group of Japan (LCSGJ) has proposed a distinct staging system that is used in many Eastern Countries. 9, 22 In the newly released 8th edition of the AJCC staging manual, while ICC remained a separate unique staging system, several new revisions to the staging of ICC were introduced. Specifically, in the 8th edition, T1 disease has been revised to include tumor size (≤5 cm vs. >5 cm); T2 was also modified to reflect an equivalent prognostic value of vascular invasion and multifocal disease. In addition, 7th edition T4 disease that described tumor growth pattern was excluded from staging with T4 disease now defined as involving local extrahepatic structures by direct invasion. The current study is important because it is one of the first reports to validate the newly proposed 8th edition ICC stating. In addition, unlike many other small single institution case series, the current study utilized a large, international, multiinstitutional cohort of patients undergoing curative-intent surgery for ICC to evaluate the 8th edition of the AJCC staging system.
In examining the T categories, the AJCC 8th edition discriminated prognosis with variable effectiveness (Fig. 1b) edition T3 patients had a higher HR of death compared with T1 patients (AJCC 8th ed. T3 vs. T1, HR 1.65 95% CI, 1.22-2.24 P = 0.001) but lower than T1b and T2 patients. As such, neither the 8th nor the 7th edition accurately stratified patients into distinct prognostic T categories.
Moreover, the major revision that involved the addition of tumor size, which had been omitted from the previous 7th AJCC T staging, did not seem to add much additional prognostic information, as reflected in the minimal improvement in the C-index (AJCC 7th ed., C-index 0.590 vs.
AJCC 8th ed., C-index 0.609; P = 0.39).
In addition, the overall staging groups based on the 8th edition had a C-index of 0.607, which was actually worse than the previous 7th edition that had a C-index of 0.637 (P = 0. 18). Of note, according to the AJCC 8th edition, higher tumor stage was associated with an expected generally lower 5-years OS (Fig. 2b) AJCC 8th edition staging did not seem to add much additional prognostic information, as reflected in the minimal improvement in the C-index (AJCC 7th ed., C-index 0.642 vs. AJCC 8th ed., C-index 0.667; P = 0.24).
The current study had several limitations. Due to the retrospective nature of the study, there may have been selection and confounding bias. However, such biases were unlikely to affect comparison of performance of the 7th versus 8th edition staging systems. Although the multi-institutional nature of the study was a strength, it also likely led to heterogeneity in treatment approach.
In conclusion, although the AJCC 8th edition was able to better stratify the risk of death of Stage III patients and T3 patients, the revised staging system still fails to discriminate prognosis for a subset of patients. Further improvements and refinements in the T-and overall staging for ICC will be necessary.
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